Search Results - "Henderson, Marian L"
-
1
Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics
Published in Neoplasia (New York, N.Y.) (01-11-2024)“…Assessing the molecular profiles of bladder cancer (BC) from patients with locally advanced or metastatic disease provides valuable insights, such as…”
Get full text
Journal Article -
2
Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care
Published in Biotech (Basel) (03-01-2024)“…Gene therapy holds promise as a life-changing option for individuals with genetic variants that give rise to disease. FDA-approved gene therapies for Spinal…”
Get full text
Journal Article -
3
The complex, dynamic SpliceOme of the small GTPase transcripts altered by technique, sex, genetics, tissue specificity, and RNA base editing
Published in Frontiers in cell and developmental biology (17-11-2022)“…The small GTPase family is well-studied in cancer and cellular physiology. With 162 annotated human genes, the family has a broad expression throughout cells…”
Get full text
Journal Article -
4
Abstract A019: TRIM29 enhances the invasion of bladder cancer cells by modulating the intermediate filament network and focal adhesions
Published in Clinical cancer research (17-05-2024)“…Abstract Background: Bladder cancer patient treatment and outcomes are determined by the tumor’s ability to invade and metastasize. Our previous work has shown…”
Get full text
Journal Article -
5
Abstract A003: Characterization of circulating tumor cells from patients with metastatic bladder cancer
Published in Clinical cancer research (17-05-2024)“…Abstract Assessing the molecular profile of bladder tumors from patients with metastatic disease is crucial for implementing personalized treatment. Current…”
Get full text
Journal Article -
6
Abstract B020: Development of novel Src-targeting strategies to block bladder cancer invasive progression
Published in Clinical cancer research (17-05-2024)“…Abstract Background: Treatment of muscle-invasive bladder cancer remains challenging and, BCG, one of the few treatments that prevents progression of high-risk…”
Get full text
Journal Article